The role of fucoidan as an anticancer therapy has developed over the last 10 years because of its involvement in the various multistep processes in cancer inhibition through modulation of cell cycle regulation, autophagy, apoptosis, metabolism and PI3K-AKT-mTOR pathways. This evidence concerns the gene AKT1 and cancer.